afamitresgene autoleucel (Tecelra)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

250 mL afamitresgene autoleucel 40000000 cells/mL Injection

More general terms

References

  1. Winstead E FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma National Cancer Institure. Aug 27, 2025 https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-tecelra-synovial-sarcoma-mage-a4